New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicenter, 1-year-long real-world study. The study is by Dr. Andres Acosta and Dr. Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN, U.S. and colleagues.
from Medical Xpress - latest medical and health news stories https://ift.tt/JAEzDZn
